Recombinant Human Endostatin Suppressed the Biological Behavior of Human Umbilical Vein Endothelial Cells Under Hypoxic and Hypoxic/Starvation Conditions In Vitro

Recombinant human endostatin (rh-endostatin) has been shown to act as an inhibitor of angiogenesis. Previous studies have indicated that rh-endostatin combined with chemotherapy can improve the objective response rate (ORR), time to progression (TTP), and clinical benefit rate (CBR) without increasi...

Full description

Saved in:
Bibliographic Details
Main Authors: Yongsheng Jia, Cuicui Zhang, Jimin Zhao, Chuanxiang Hu, Xiaoyong Yang, Yan Zhang
Format: Article
Language:English
Published: Wiley 2025-01-01
Series:Analytical Cellular Pathology
Online Access:http://dx.doi.org/10.1155/ancp/3475731
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850216852905525248
author Yongsheng Jia
Cuicui Zhang
Jimin Zhao
Chuanxiang Hu
Xiaoyong Yang
Yan Zhang
author_facet Yongsheng Jia
Cuicui Zhang
Jimin Zhao
Chuanxiang Hu
Xiaoyong Yang
Yan Zhang
author_sort Yongsheng Jia
collection DOAJ
description Recombinant human endostatin (rh-endostatin) has been shown to act as an inhibitor of angiogenesis. Previous studies have indicated that rh-endostatin combined with chemotherapy can improve the objective response rate (ORR), time to progression (TTP), and clinical benefit rate (CBR) without increasing toxicity. However, this function has seldom been reported in normal cells. The aim of our study was to explore the effect of rh-endostatin on the biological behavior of human umbilical vein endothelial cells (HUVECs) under different conditions in vitro. Confluent HUVECs were cultured under normoxic, hypoxic, or hypoxic/starvation (H/S) conditions and then treated with rh-endostatin. An MTT assay was used to assess cell proliferation, and HUVEC tube formation and migration were assessed via a cell tubule formation assay and a migration assay. The expression of endoglin (CD105) was assessed by flow cytometry (FCM). Rh-endostatin inhibited the proliferation, migration, and tube formation of HUVECs under normoxic, hypoxic, and H/S conditions. Compared with that in the normoxia group, the expression of CD105 was not different in the hypoxia 24 h group, but in the starvation and hypoxia/starvation groups, the expression of CD105 was upregulated. Rh-endostatin downregulated the expression of CD105 under all the study conditions. Here we found rh-endostatin suppressed the biological behavior of HUVECs under hypoxic and H/S conditions. As the concentration increased, the effect of rh-endostatin on the biological behavior of HUVECs was not greatly enhanced. Rh-endostatin did not promote malignant biological behavior or CD105 expression. Since CD105 may induce endothelial-to-mesenchymal transition in HUVECs, we hypothesized that rh-endostatin may inhibit the malignant biological behavior of HUVECs under hypoxic conditions in vitro.
format Article
id doaj-art-1b832bcab1ad4bcf982a01caee19bde4
institution OA Journals
issn 2210-7185
language English
publishDate 2025-01-01
publisher Wiley
record_format Article
series Analytical Cellular Pathology
spelling doaj-art-1b832bcab1ad4bcf982a01caee19bde42025-08-20T02:08:12ZengWileyAnalytical Cellular Pathology2210-71852025-01-01202510.1155/ancp/3475731Recombinant Human Endostatin Suppressed the Biological Behavior of Human Umbilical Vein Endothelial Cells Under Hypoxic and Hypoxic/Starvation Conditions In VitroYongsheng Jia0Cuicui Zhang1Jimin Zhao2Chuanxiang Hu3Xiaoyong Yang4Yan Zhang5Thyroid and Neck DepartmentKey Laboratory of Cancer Prevention and TherapyThyroid and Neck DepartmentTianjin’s Clinical Research Center for CancerThyroid and Neck DepartmentThyroid and Neck DepartmentRecombinant human endostatin (rh-endostatin) has been shown to act as an inhibitor of angiogenesis. Previous studies have indicated that rh-endostatin combined with chemotherapy can improve the objective response rate (ORR), time to progression (TTP), and clinical benefit rate (CBR) without increasing toxicity. However, this function has seldom been reported in normal cells. The aim of our study was to explore the effect of rh-endostatin on the biological behavior of human umbilical vein endothelial cells (HUVECs) under different conditions in vitro. Confluent HUVECs were cultured under normoxic, hypoxic, or hypoxic/starvation (H/S) conditions and then treated with rh-endostatin. An MTT assay was used to assess cell proliferation, and HUVEC tube formation and migration were assessed via a cell tubule formation assay and a migration assay. The expression of endoglin (CD105) was assessed by flow cytometry (FCM). Rh-endostatin inhibited the proliferation, migration, and tube formation of HUVECs under normoxic, hypoxic, and H/S conditions. Compared with that in the normoxia group, the expression of CD105 was not different in the hypoxia 24 h group, but in the starvation and hypoxia/starvation groups, the expression of CD105 was upregulated. Rh-endostatin downregulated the expression of CD105 under all the study conditions. Here we found rh-endostatin suppressed the biological behavior of HUVECs under hypoxic and H/S conditions. As the concentration increased, the effect of rh-endostatin on the biological behavior of HUVECs was not greatly enhanced. Rh-endostatin did not promote malignant biological behavior or CD105 expression. Since CD105 may induce endothelial-to-mesenchymal transition in HUVECs, we hypothesized that rh-endostatin may inhibit the malignant biological behavior of HUVECs under hypoxic conditions in vitro.http://dx.doi.org/10.1155/ancp/3475731
spellingShingle Yongsheng Jia
Cuicui Zhang
Jimin Zhao
Chuanxiang Hu
Xiaoyong Yang
Yan Zhang
Recombinant Human Endostatin Suppressed the Biological Behavior of Human Umbilical Vein Endothelial Cells Under Hypoxic and Hypoxic/Starvation Conditions In Vitro
Analytical Cellular Pathology
title Recombinant Human Endostatin Suppressed the Biological Behavior of Human Umbilical Vein Endothelial Cells Under Hypoxic and Hypoxic/Starvation Conditions In Vitro
title_full Recombinant Human Endostatin Suppressed the Biological Behavior of Human Umbilical Vein Endothelial Cells Under Hypoxic and Hypoxic/Starvation Conditions In Vitro
title_fullStr Recombinant Human Endostatin Suppressed the Biological Behavior of Human Umbilical Vein Endothelial Cells Under Hypoxic and Hypoxic/Starvation Conditions In Vitro
title_full_unstemmed Recombinant Human Endostatin Suppressed the Biological Behavior of Human Umbilical Vein Endothelial Cells Under Hypoxic and Hypoxic/Starvation Conditions In Vitro
title_short Recombinant Human Endostatin Suppressed the Biological Behavior of Human Umbilical Vein Endothelial Cells Under Hypoxic and Hypoxic/Starvation Conditions In Vitro
title_sort recombinant human endostatin suppressed the biological behavior of human umbilical vein endothelial cells under hypoxic and hypoxic starvation conditions in vitro
url http://dx.doi.org/10.1155/ancp/3475731
work_keys_str_mv AT yongshengjia recombinanthumanendostatinsuppressedthebiologicalbehaviorofhumanumbilicalveinendothelialcellsunderhypoxicandhypoxicstarvationconditionsinvitro
AT cuicuizhang recombinanthumanendostatinsuppressedthebiologicalbehaviorofhumanumbilicalveinendothelialcellsunderhypoxicandhypoxicstarvationconditionsinvitro
AT jiminzhao recombinanthumanendostatinsuppressedthebiologicalbehaviorofhumanumbilicalveinendothelialcellsunderhypoxicandhypoxicstarvationconditionsinvitro
AT chuanxianghu recombinanthumanendostatinsuppressedthebiologicalbehaviorofhumanumbilicalveinendothelialcellsunderhypoxicandhypoxicstarvationconditionsinvitro
AT xiaoyongyang recombinanthumanendostatinsuppressedthebiologicalbehaviorofhumanumbilicalveinendothelialcellsunderhypoxicandhypoxicstarvationconditionsinvitro
AT yanzhang recombinanthumanendostatinsuppressedthebiologicalbehaviorofhumanumbilicalveinendothelialcellsunderhypoxicandhypoxicstarvationconditionsinvitro